Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stopped early
Conditions studied: Liver Cancer, Hepatitis B, Hepatitis C, Hepatobiliary Cancers Liver, Hepatobiliary Cancers
In brief
Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.
Key facts
- Study ID
- NCT00767936
- Run by
- Stanford University
- People needed
- 135
- Starts
- 2008-03-01
- Expected to finish
- 2013-09-01
- Last updated by the study team
- 2016-06-29
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.